Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Non-Invasive blood pressure / Body Weight
|
HOM
|
11f:7m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Non-Invasive blood pressure / Systolic arterial pressure
|
HOM
|
346f:272m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand skin color brightness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand skin relative color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand skin shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear skin color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand skin spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand skin texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand skin wetness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear skin color brightness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail curvature
|
HOM
|
13f:11m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear skin relative color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear skin shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / BN startle magnitude
|
HOM
|
13f:13m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0329
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Number of centre entries
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.418
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Latency to centre entry
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.244
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / PP2 + pulse startle magnitude
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.266
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / PP3 + pulse startle magnitude
|
HOM
|
13f:13m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.418
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / 110dB startle magnitude
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.590
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / PP1 + pulse startle magnitude
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.624
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / PP3 startle magnitude
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.363
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Haematology / Mean corpuscular haemoglobin
|
HOM
|
12f:12m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00115
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / PP4 startle magnitude
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.913
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / PP1 startle magnitude
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.335
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Haematology / Platelets count
|
HOM
|
13f:12m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0833
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / PP2 startle magnitude
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.921
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail skin spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail skin texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot skin color brightness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot skin relative color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot skin shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Body Weight / Body Weight Curve Pipeline One
|
HOM
|
68f:66m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot skin color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Body Weight / Body Weight Curve Pipeline Two
|
HOM
|
69f:65m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand skin color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot skin spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot skin texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot skin wetness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Body weight
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Lean mass
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0468
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Bone Mineral Density (excluding skull)
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
9.84×10-07
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Body weight
|
HOM
|
12f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Right eye blood vessels pattern
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail skin wetness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Fat mass
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.474
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Right eye blood vessels structure
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Right eye blood vessels
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Left eye blood vessels pattern
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Left eye blood vessels structure
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Left eye blood vessels
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Right optic disc
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head bone curvature
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Eye
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head width
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail skin color brightness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Cornea
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail skin relative color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Eyelid closure
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail skin shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Eye (+) blood presence
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Right retina structure
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Eye size
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail skin color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Right retina pigmentation
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head bone symmetry
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / vibrissa hair curvature
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Simplified IPGTT / Glucose response AUC
|
HOM
|
10f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.929
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / vibrissa hair length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / vibrissa hair orientation
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / upper lip shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / muzzle/snout length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / muzzle/snout width
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / vibrissa hair
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Bone Mineral Content
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
1.57×10-09
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / vibrissa hair presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Simplified IPGTT / Body Weight
|
HOM
|
10f:10m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Simplified IPGTT / Blood glucose concentration
|
HOM
|
50f:50m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / Global prepulse inhibition
|
HOM
|
13f:13m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.782
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / Prepulse inhibition - PP3
|
HOM
|
13f:13m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.906
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / Prepulse inhibition - PP4
|
HOM
|
13f:13m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.869
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Right retina
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Left optic disc
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Lens
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Left retina structure
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Cornea vascularisation
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Left retina pigmentation
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Cornea opacity
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Left retina
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Description
|
HOM
|
1f:4m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect ophthalmoscopy / Eye
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Bone area (BMC/BMD)
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, including Weight
|
8.25×10-06
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Iris/pupil shape
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Iris/pupil position
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Lean/Body weight
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.196
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Iris/pupil
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / Fat/Body weight
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.363
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Lens opacity
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
DEXA / BMC/Body weight
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
1.18×10-06
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Iris pigment
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Slit Lamp / Iris/pupil light response
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / Body weight
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Periphery average speed
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.0490
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Periphery permanence time
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.246
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / PP4 + pulse startle magnitude
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.234
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Periphery resting time
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.522
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Periphery distance travelled
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.0287
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Whole arena average speed
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.0318
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Whole arena permanence time
|
HOM
|
14f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Whole arena resting time
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.193
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Heart weight/tibia length / Heart weight
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.509
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Heart weight/tibia length / Body weight
|
HOM
|
12f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Haematology / White blood cell count
|
HOM
|
13f:12m
|
Linear Mixed Model framework, LME, not including Weight
|
0.272
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Haematology / Red blood cell count
|
HOM
|
13f:12m
|
Linear Mixed Model framework, LME, not including Weight
|
4.23×10-06
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Haematology / Haemoglobin
|
HOM
|
12f:12m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
1.80×10-08
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Centre average speed
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
5.06×10-05
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Centre permanence time
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.201
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Centre resting time
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.111
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Centre distance travelled
|
HOM
|
14f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.425
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / Prepulse inhibition - PP1
|
HOM
|
13f:13m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.254
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Acoustic Startle&PPI / Prepulse inhibition - PP2
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.913
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Open-field / Distance travelled
|
HOM
|
56f:52m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.589
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.812
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.350
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.660
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
12f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.817
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tooth presence
|
HOM
|
13f:11m
|
Fisher Exact Test framework
|
0.0955
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tooth relative color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tooth size
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.209
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.325
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.631
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.637
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / lower lip shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0634
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.301
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0152
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0824
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tooth
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.823
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.893
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tooth morphology
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear position
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / eye opacity
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / eye presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / eye size
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / eye wetness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear size
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear rotation
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / eye
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / T cell CD8+ percentage
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
1.26×10-07
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / T cell CD4+ percentage
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
1.80×10-05
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / eye color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / vagina structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Grip-Strength / Forelimb grip strength measurement
|
HOM
|
45f:39m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / adult mouse thickness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / fat distribution
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / testis
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Grip-Strength / Forelimb and hindlimb grip strength measurement
|
HOM
|
45f:39m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Grip-Strength / Body weight
|
HOM
|
15f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / coat hair
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / testis size
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / vagina
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / adult mouse weight
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / adult mouse
|
HOM
|
13f:11m
|
Fisher Exact Test framework
|
0.0414
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / adult mouse abnormality description
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / vagina size
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / adult mouse length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / vagina presence
|
HOM
|
13f:11m
|
Fisher Exact Test framework
|
0.682
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / eyelid closure
|
HOM
|
13f:11m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / eyelid presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Rotarod / Passive rotation
|
HOM
|
45f:39m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Rotarod / Latency to fall
|
HOM
|
45f:39m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Rotarod / General comments about the mouse
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Trunk curl
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Rotarod / Body weight
|
HOM
|
15f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Positional passivity
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Touch escape
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.238
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Startle response
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.625
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / coat hair color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Corneal reflex
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Pinna reflex
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Limb grasping
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / forelimb length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / coat hair structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head + coat hair color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / forelimb thickness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / forelimb shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head + coat hair color pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head + coat hair presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / coat hair placement
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / General comments about the mouse
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / forelimb size
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / coat hair spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Vocalisation
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / coat hair distribution
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / forelimb angle
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Evidence of biting
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.00527
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / forelimb flexibility
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / coat hair texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Contact righting reflex
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.103
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / testis presence
|
HOM
|
13f:11m
|
Fisher Exact Test framework
|
0.682
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / testis structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / coat hair color pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / forelimb
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / coat hair presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Palpebral closure
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Urination
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.822
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Defecation
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.545
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Tremor
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.113
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Gait
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Locomotor activity
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.430
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Transfer arousal
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.749
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Lacrimation
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand digit presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / back + coat hair presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / back + coat hair placement
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand digit structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / back + coat hair spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head + coat hair texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Tail elevation
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.0132
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head + coat hair structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand footpad structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Pelvic elevation
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.00512
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / back + coat hair color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand digit count
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / back + coat hair color pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand digit thickness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Grip-Strength / Forelimb grip strength measurement mean
|
HOM
|
15f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.936
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / forelimb joint structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Grip-Strength / Forelimb and hindlimb grip strength measurement mean
|
HOM
|
15f:13m
|
Linear Mixed Model framework, LME, including Weight
|
0.719
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head + coat hair placement
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Grip-Strength / Forelimb grip strength normalised against body weight
|
HOM
|
15f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.296
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head + coat hair spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand size
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Grip-Strength / Forelimb and hindlimb grip strength normalised against body weight
|
HOM
|
15f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.282
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / head + coat hair distribution
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / Number of leukocytes
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0573
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / stomach + coat hair distribution
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hindlimb joint structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / NK cell percentage
|
HOM
|
13f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.217
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / stomach + coat hair texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / Granulocyte Gr1+ percentage
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.464
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / Monocyte gate
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.403
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hindlimb flexibility
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / stomach + coat hair color pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Modified SHIRPA / Body position
|
HOM
|
13f:13m
|
Fisher Exact Test framework
|
0.00318
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / CD25+ percentage of CD4+ T cells
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.556
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hindlimb length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / stomach + coat hair presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / T cell CD3+ percentage
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
9.34×10-08
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hindlimb thickness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / stomach + coat hair placement
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / Mature B cells IgD+ percentage
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.544
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / stomach + coat hair spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hindlimb shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
FACs Analysis / B cell CD19+ percentage
|
HOM
|
13f:12m
|
Linear Mixed Model framework, LME, not including Weight
|
5.80×10-06
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hindlimb
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / back + coat hair distribution
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / back + coat hair texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / back + coat hair structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hindlimb size
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / stomach + coat hair color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hindlimb angle
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / hand digit length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0376
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.643
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Calorimetry / Carbon dioxide production
|
HOM
|
693f:879m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.373
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.800
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Calorimetry / Oxygen consumption
|
HOM
|
693f:879m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Calorimetry / Body mass after experiment
|
HOM
|
10f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.883
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Calorimetry / Body mass before experiment
|
HOM
|
10f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / skin color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / skin wetness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot digit thickness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / skin color brightness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot digit presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / skin relative color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot digit structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / skin shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot digit length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / skin
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot footpad structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / skin spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / skin texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot digit count
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
X-Ray / Alive
|
HOM
|
3f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / foot size
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / stomach + coat hair structure
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Hot Plate / Comment on other behaviours
|
HOM
|
10f:12m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Hot Plate / Time of first response
|
HOM
|
13f:13m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0934
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Hot Plate / Type of response
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Hot Plate / Body weight
|
HOM
|
13f:13m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0210
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.186
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.465
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.678
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.272
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
5f:1m
|
Linear Mixed Model framework, LME, not including Weight
|
0.937
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.524
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.815
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.231
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.399
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.338
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.834
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00132
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.928
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0753
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.469
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nose skin color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0760
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0896
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear skin spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0615
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.485
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail width
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear skin texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / ear skin wetness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
6f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.220
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
5f:1m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.434
|
Successful |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nail curvature
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nose skin wetness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nose skin color brightness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nail color brightness
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / tail
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nose skin relative color
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nose skin shape
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nail presence
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nose skin spatial pattern
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nail length
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nose skin texture
|
HOM
|
13f:11m
|
|
|
NotProcessed |
Acp2tm1a(EUCOMM)Wtsi
|
MRC Harwell
|
Dysmorphology / nail angle
|
HOM
|
13f:11m
|
|
|
NotProcessed |